Regulations.gov document
Premarket Approval Response from FDA CDRH to Obalon Therapeutics, Inc. P160001
Other · FDA-2016-M-2651 · posted Sep 29, 2016
Key facts
| Document ID | FDA-2016-M-2651-0001 |
|---|---|
| Title | Premarket Approval Response from FDA CDRH to Obalon Therapeutics, Inc. P160001 |
| Document type | Other |
| Subtype | Approval |
| Agency | FDA |
| Docket | FDA-2016-M-2651 |
| Posted | Sep 29, 2016 |
| Comment period opens | Sep 29, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: